Global Interventional Cardiology Market Analysis and Forecast 2024-2030

Global Interventional Cardiology Market Analysis and Forecast 2024-2030


Summary

Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.

According to APO Research, The global Interventional Cardiology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Interventional Cardiology include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE and Co. KG, Bard Peripheral Vascular,Inc, TERUMO CORPORATION, KANEKA and OrbusNeich Medical, BV, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Interventional Cardiology, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Interventional Cardiology, also provides the sales of main regions and countries. Of the upcoming market potential for Interventional Cardiology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interventional Cardiology sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Interventional Cardiology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Interventional Cardiology sales, projected growth trends, production technology, application and end-user industry.

Interventional Cardiology segment by Company

Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE and Co. KG
Bard Peripheral Vascular,Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort
Interventional Cardiology segment by Type

Cardiology Catheters
Guidewires
Balloon Catheters
Coronary Stents
Fractional Flow Reserve
Intravascular Ultrasound
Interventional Cardiology segment by Application

Hospitals
Clinics
Others
Interventional Cardiology segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interventional Cardiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Interventional Cardiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interventional Cardiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Interventional Cardiology in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Interventional Cardiology manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interventional Cardiology sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Interventional Cardiology Market by Type
1.2.1 Global Interventional Cardiology Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Cardiology Catheters
1.2.3 Guidewires
1.2.4 Balloon Catheters
1.2.5 Coronary Stents
1.2.6 Fractional Flow Reserve
1.2.7 Intravascular Ultrasound
1.3 Interventional Cardiology Market by Application
1.3.1 Global Interventional Cardiology Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Interventional Cardiology Market Dynamics
2.1 Interventional Cardiology Industry Trends
2.2 Interventional Cardiology Industry Drivers
2.3 Interventional Cardiology Industry Opportunities and Challenges
2.4 Interventional Cardiology Industry Restraints
3 Global Market Growth Prospects
3.1 Global Interventional Cardiology Revenue Estimates and Forecasts (2019-2030)
3.2 Global Interventional Cardiology Revenue by Region
3.2.1 Global Interventional Cardiology Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Interventional Cardiology Revenue by Region (2019-2024)
3.2.3 Global Interventional Cardiology Revenue by Region (2025-2030)
3.2.4 Global Interventional Cardiology Revenue Market Share by Region (2019-2030)
3.3 Global Interventional Cardiology Sales Estimates and Forecasts 2019-2030
3.4 Global Interventional Cardiology Sales by Region
3.4.1 Global Interventional Cardiology Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Interventional Cardiology Sales by Region (2019-2024)
3.4.3 Global Interventional Cardiology Sales by Region (2025-2030)
3.4.4 Global Interventional Cardiology Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Interventional Cardiology Revenue by Manufacturers
4.1.1 Global Interventional Cardiology Revenue by Manufacturers (2019-2024)
4.1.2 Global Interventional Cardiology Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Interventional Cardiology Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Interventional Cardiology Sales by Manufacturers
4.2.1 Global Interventional Cardiology Sales by Manufacturers (2019-2024)
4.2.2 Global Interventional Cardiology Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Interventional Cardiology Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Interventional Cardiology Sales Price by Manufacturers (2019-2024)
4.4 Global Interventional Cardiology Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Interventional Cardiology Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Interventional Cardiology Manufacturers, Product Type & Application
4.7 Global Interventional Cardiology Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Interventional Cardiology Market CR5 and HHI
4.8.2 2023 Interventional Cardiology Tier 1, Tier 2, and Tier 3
5 Interventional Cardiology Market by Type
5.1 Global Interventional Cardiology Revenue by Type
5.1.1 Global Interventional Cardiology Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Interventional Cardiology Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Interventional Cardiology Revenue Market Share by Type (2019-2030)
5.2 Global Interventional Cardiology Sales by Type
5.2.1 Global Interventional Cardiology Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Interventional Cardiology Sales by Type (2019-2030) & (K Units)
5.2.3 Global Interventional Cardiology Sales Market Share by Type (2019-2030)
5.3 Global Interventional Cardiology Price by Type
6 Interventional Cardiology Market by Application
6.1 Global Interventional Cardiology Revenue by Application
6.1.1 Global Interventional Cardiology Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Interventional Cardiology Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Interventional Cardiology Revenue Market Share by Application (2019-2030)
6.2 Global Interventional Cardiology Sales by Application
6.2.1 Global Interventional Cardiology Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Interventional Cardiology Sales by Application (2019-2030) & (K Units)
6.2.3 Global Interventional Cardiology Sales Market Share by Application (2019-2030)
6.3 Global Interventional Cardiology Price by Application
7 Company Profiles
7.1 Medtronic, Inc.
7.1.1 Medtronic, Inc. Comapny Information
7.1.2 Medtronic, Inc. Business Overview
7.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Medtronic, Inc. Interventional Cardiology Product Portfolio
7.1.5 Medtronic, Inc. Recent Developments
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Comapny Information
7.2.2 Boston Scientific Corporation Business Overview
7.2.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Boston Scientific Corporation Interventional Cardiology Product Portfolio
7.2.5 Boston Scientific Corporation Recent Developments
7.3 Abbott Vascular
7.3.1 Abbott Vascular Comapny Information
7.3.2 Abbott Vascular Business Overview
7.3.3 Abbott Vascular Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Abbott Vascular Interventional Cardiology Product Portfolio
7.3.5 Abbott Vascular Recent Developments
7.4 MINVASYS S.A.S.
7.4.1 MINVASYS S.A.S. Comapny Information
7.4.2 MINVASYS S.A.S. Business Overview
7.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 MINVASYS S.A.S. Interventional Cardiology Product Portfolio
7.4.5 MINVASYS S.A.S. Recent Developments
7.5 BIOTRONIK SE and Co. KG
7.5.1 BIOTRONIK SE and Co. KG Comapny Information
7.5.2 BIOTRONIK SE and Co. KG Business Overview
7.5.3 BIOTRONIK SE and Co. KG Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BIOTRONIK SE and Co. KG Interventional Cardiology Product Portfolio
7.5.5 BIOTRONIK SE and Co. KG Recent Developments
7.6 Bard Peripheral Vascular,Inc
7.6.1 Bard Peripheral Vascular,Inc Comapny Information
7.6.2 Bard Peripheral Vascular,Inc Business Overview
7.6.3 Bard Peripheral Vascular,Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Bard Peripheral Vascular,Inc Interventional Cardiology Product Portfolio
7.6.5 Bard Peripheral Vascular,Inc Recent Developments
7.7 TERUMO CORPORATION
7.7.1 TERUMO CORPORATION Comapny Information
7.7.2 TERUMO CORPORATION Business Overview
7.7.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 TERUMO CORPORATION Interventional Cardiology Product Portfolio
7.7.5 TERUMO CORPORATION Recent Developments
7.8 KANEKA
7.8.1 KANEKA Comapny Information
7.8.2 KANEKA Business Overview
7.8.3 KANEKA Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 KANEKA Interventional Cardiology Product Portfolio
7.8.5 KANEKA Recent Developments
7.9 OrbusNeich Medical, BV
7.9.1 OrbusNeich Medical, BV Comapny Information
7.9.2 OrbusNeich Medical, BV Business Overview
7.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 OrbusNeich Medical, BV Interventional Cardiology Product Portfolio
7.9.5 OrbusNeich Medical, BV Recent Developments
7.10 Cordis Cashel
7.10.1 Cordis Cashel Comapny Information
7.10.2 Cordis Cashel Business Overview
7.10.3 Cordis Cashel Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Cordis Cashel Interventional Cardiology Product Portfolio
7.10.5 Cordis Cashel Recent Developments
7.11 Kimal Plc
7.11.1 Kimal Plc Comapny Information
7.11.2 Kimal Plc Business Overview
7.11.3 Kimal Plc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Kimal Plc Interventional Cardiology Product Portfolio
7.11.5 Kimal Plc Recent Developments
7.12 Volcano Corporation
7.12.1 Volcano Corporation Comapny Information
7.12.2 Volcano Corporation Business Overview
7.12.3 Volcano Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Volcano Corporation Interventional Cardiology Product Portfolio
7.12.5 Volcano Corporation Recent Developments
7.13 Siemens Medical Solutions USA, Inc
7.13.1 Siemens Medical Solutions USA, Inc Comapny Information
7.13.2 Siemens Medical Solutions USA, Inc Business Overview
7.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Siemens Medical Solutions USA, Inc Interventional Cardiology Product Portfolio
7.13.5 Siemens Medical Solutions USA, Inc Recent Developments
7.14 Lepu
7.14.1 Lepu Comapny Information
7.14.2 Lepu Business Overview
7.14.3 Lepu Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Lepu Interventional Cardiology Product Portfolio
7.14.5 Lepu Recent Developments
7.15 MicroPort
7.15.1 MicroPort Comapny Information
7.15.2 MicroPort Business Overview
7.15.3 MicroPort Interventional Cardiology Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 MicroPort Interventional Cardiology Product Portfolio
7.15.5 MicroPort Recent Developments
8 North America
8.1 North America Interventional Cardiology Market Size by Type
8.1.1 North America Interventional Cardiology Revenue by Type (2019-2030)
8.1.2 North America Interventional Cardiology Sales by Type (2019-2030)
8.1.3 North America Interventional Cardiology Price by Type (2019-2030)
8.2 North America Interventional Cardiology Market Size by Application
8.2.1 North America Interventional Cardiology Revenue by Application (2019-2030)
8.2.2 North America Interventional Cardiology Sales by Application (2019-2030)
8.2.3 North America Interventional Cardiology Price by Application (2019-2030)
8.3 North America Interventional Cardiology Market Size by Country
8.3.1 North America Interventional Cardiology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Interventional Cardiology Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Interventional Cardiology Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Interventional Cardiology Market Size by Type
9.1.1 Europe Interventional Cardiology Revenue by Type (2019-2030)
9.1.2 Europe Interventional Cardiology Sales by Type (2019-2030)
9.1.3 Europe Interventional Cardiology Price by Type (2019-2030)
9.2 Europe Interventional Cardiology Market Size by Application
9.2.1 Europe Interventional Cardiology Revenue by Application (2019-2030)
9.2.2 Europe Interventional Cardiology Sales by Application (2019-2030)
9.2.3 Europe Interventional Cardiology Price by Application (2019-2030)
9.3 Europe Interventional Cardiology Market Size by Country
9.3.1 Europe Interventional Cardiology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Interventional Cardiology Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Interventional Cardiology Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Interventional Cardiology Market Size by Type
10.1.1 China Interventional Cardiology Revenue by Type (2019-2030)
10.1.2 China Interventional Cardiology Sales by Type (2019-2030)
10.1.3 China Interventional Cardiology Price by Type (2019-2030)
10.2 China Interventional Cardiology Market Size by Application
10.2.1 China Interventional Cardiology Revenue by Application (2019-2030)
10.2.2 China Interventional Cardiology Sales by Application (2019-2030)
10.2.3 China Interventional Cardiology Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Interventional Cardiology Market Size by Type
11.1.1 Asia Interventional Cardiology Revenue by Type (2019-2030)
11.1.2 Asia Interventional Cardiology Sales by Type (2019-2030)
11.1.3 Asia Interventional Cardiology Price by Type (2019-2030)
11.2 Asia Interventional Cardiology Market Size by Application
11.2.1 Asia Interventional Cardiology Revenue by Application (2019-2030)
11.2.2 Asia Interventional Cardiology Sales by Application (2019-2030)
11.2.3 Asia Interventional Cardiology Price by Application (2019-2030)
11.3 Asia Interventional Cardiology Market Size by Country
11.3.1 Asia Interventional Cardiology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Interventional Cardiology Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Interventional Cardiology Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Interventional Cardiology Market Size by Type
12.1.1 MEALA Interventional Cardiology Revenue by Type (2019-2030)
12.1.2 MEALA Interventional Cardiology Sales by Type (2019-2030)
12.1.3 MEALA Interventional Cardiology Price by Type (2019-2030)
12.2 MEALA Interventional Cardiology Market Size by Application
12.2.1 MEALA Interventional Cardiology Revenue by Application (2019-2030)
12.2.2 MEALA Interventional Cardiology Sales by Application (2019-2030)
12.2.3 MEALA Interventional Cardiology Price by Application (2019-2030)
12.3 MEALA Interventional Cardiology Market Size by Country
12.3.1 MEALA Interventional Cardiology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Interventional Cardiology Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Interventional Cardiology Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Interventional Cardiology Value Chain Analysis
13.1.1 Interventional Cardiology Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Interventional Cardiology Production Mode & Process
13.2 Interventional Cardiology Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Interventional Cardiology Distributors
13.2.3 Interventional Cardiology Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings